InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Grossman Jerrold B, Director. Officer active across 1 companies, notably Adma Biologics, INC.. Cumulatively, 5 disclosures have been published. Total volume traded: €343k. The latest transaction was disclosed on 12 May 2026 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
US$85,31912,500 shares@ US$6.825549.8% of flow
Common Stock
SEC:0001140361-26-021150·
Ideal exit: 6 Feb 2027 (T+270)
€85,31912,500 shares@ €6.82550.0045% mcap24.9% of flow
Common Stock
SEC:0001140361-26-021150:0·
Ideal exit: 6 Feb 2027 (T+270)
026,586 shares0
Common Stock
SEC:0001140361-22-008670:0·
€86,120100,000 shares@ €0.86120.0045% mcap50.2% of flow
Common Stock
SEC:0001140361-21-035381·
Ideal exit: 22 Jul 2022 (T+270)
€86,120100,000 shares@ €0.86120.0045% mcap25.1% of flow
Common Stock
SEC:0001140361-21-035381:0·
Ideal exit: 22 Jul 2022 (T+270)
5 of 5 declarations
About Grossman Jerrold B
Grossman Jerrold B is a Board Member at ADMA BIOLOGICS, INC. He contributes to the governance and strategy of the company, bringing his expertise in leadership and decision-making.
